SAE -- Leronlimab (0/28). Placebo (1/28) 3.57 O

Quote:

---

SAE -- Leronlimab (0/28). Placebo (1/28) 3.57

---

Oh, okay. NOW I see why, shortly after this trial, Leronlimab was clamped into a two year safety hold. It was due to the fact that you might run the risk of a serious adverse event if you DIDN'T take Leron. Okay, that makes sense. Better to just get rid of the drug, stop all clinical trials, and that way nobody will have an adverse event.

Gotta hand it to the FDA. Sheer genius, sometimes, those guys. Thank God they are protecting the people in this country from adverse drug effects. I sleep better at night, knowing they're on the job.